April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Multi-Tissue Ocular Melanocytosis: Risk of Development of Uveal Melanoma
Author Affiliations & Notes
  • A. Mashayekhi
    Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania
  • C. Park
    Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania
  • C. L. Shields
    Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania
  • J. A. Shields
    Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania
  • Footnotes
    Commercial Relationships  A. Mashayekhi, None; C. Park, None; C.L. Shields, None; J.A. Shields, None.
  • Footnotes
    Support  Eye Tumor Research Foundation (Philadelphia, PA)
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 853. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Mashayekhi, C. Park, C. L. Shields, J. A. Shields; Multi-Tissue Ocular Melanocytosis: Risk of Development of Uveal Melanoma. Invest. Ophthalmol. Vis. Sci. 2010;51(13):853.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Lifetime prevalence of uveal melanoma in patients with ocular melanocytosis has been estimated at 1/400. This study aimed to determine the incidence of uveal melanoma in eyes with ocular melanocytosis that have involvement of more than one ocular/periocular tissue.

Methods: : Review of medical records of ocular melanocytosis patients that had involvement of two or more of the following 5 tissues: skin, palate, sclera, iris, and choroid.

Results: : 169 eyes of 154 patients were included. Mean patient age was 39 years (range, 1-88 years) and 89 patients (58%) were female. Racial distribution included Caucasian (84%), African-American (5%), Hispanic (5%), Asian (3%), and Indian (2%). Melanocytosis was unilateral in 137 (89%) and bilateral in 17 patients (11%). Four eyes (2%) had involvement of all 5 tissues. 43 eyes (25%) had involvement of 4 tissues (39 with skin, sclera, iris, and choroid), 69 eyes (41%) had involvement of 3 tissues (59 with sclera, iris, and choroid), and 53 eyes (31%) had involvement of 2 tissues (28 with sclera and choroid).Twenty-eight eyes presented with uveal melanoma at first visit. Of 141 eyes without uveal melanoma at first visit 92 had subsequent follow-up (mean follow-up duration, 69 months), two of which (2/92=1/46) developed choroidal melanoma.

Conclusions: : Risk of developing uveal melanoma in ocular melanocytosis eyes that have involvement of more than one ocular/periocular tissue seems to be much higher than has been previously estimated for ocular melanocytosis patients in general.

Keywords: melanoma • clinical (human) or epidemiologic studies: natural history • oncology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×